TGFB1 and Hepatic fibrosis: Garcinol administration reduced aspartate transaminase activity and showed hepatoprotective and anti-fibrotic effects by reducing accumulation of extracellular matrix and expression of α-smooth muscle actin, TGF-β1 and Smad 2/3 proteins in dimethylnitrosamine-induced liver fibrosis in rats [38].